BamSEC and AlphaSense Join Forces
Learn More

Atossa Therapeutics Inc.

NASDAQ: ATOS    
Share price (1/8/25): $0.92    
Market cap (1/8/25): $116 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from S-3 45 pages Definitions and Incorporation by Reference
12/34/56
EX-4.1
from 8-K 3 pages Form of Common Stock Purchase Warrant Atossa Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 3 pages Form of Common Stock Purchase Warrant Atossa Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 3 pages Form of Common Stock Purchase Warrant Atossa Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 3 pages Form of Common Stock Purchase Warrant Atossa Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 17 pages Atossa Therapeutics, Inc. and Vstock Transfer, LLC, as Warrant Agent Form of Warrant Agency Agreement Dated as of __, 2020 Form of Warrant Agency Agreement
12/34/56
EX-4.1
from 8-K 17 pages Form of Common Stock Purchase Warrant Atossa Therapeutics, Inc
12/34/56
EX-4.10
from S-1/A 17 pages Atossa Therapeutics, Inc. and Vstock Transfer, LLC, as Warrant Agent Form of Warrant Agency Agreement Dated as of __, 2020 Form of Warrant Agency Agreement
12/34/56
EX-4.9
from S-1/A 17 pages Form of Common Stock Purchase Warrant Atossa Therapeutics, Inc
12/34/56
EX-4.1
from S-3 42 pages Atossa Therapeutics, Inc. Debt Securities Indenture Dated as of [ ] [ ]., as Trustee
12/34/56
EX-4.1
from 10-Q ~5 pages Incentive Stock Option Agreement Under the Atossa Therapeutics, Inc. 2020 Stock Incentive Plan
12/34/56
EX-4.1
from 8-K ~5 pages Stock Option Agreement Under the Atossa Therapeutics, Inc. 2020 Stock Incentive Plan
12/34/56
EX-4.16
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 17 pages Atossa Genetics Inc. 2010 Stock Option and Incentive Plan (As Amended by the Board of Directors on January 13, 2019 (The “2019 Amendment”) Subject to and Conditioned Upon Stockholder Approval)
12/34/56
EX-4.1
from 8-K 6 pages Stock Option Agreement Under the Atossa Genetics Inc. 2010 Stock Option and Incentive Plan (As Amended January 13, 2019) Name of Optionee: No. of Option Shares: Option Exercise Price Per Share: Vesting Commencement Date: Grant Date: Expiration Date
12/34/56
EX-4.1
from 8-K 6 pages Stock Option Agreement Under the Atossa Genetics Inc. 2010 Stock Option and Incentive Plan
12/34/56
EX-4.1
from 8-K 36 pages Atossa Genetics Inc. Warrant Agency Agreement
12/34/56
EX-4.4
from S-1/A 2 pages Form of Non-Transferable Subscription Rights Certificate
12/34/56
EX-4.3
from S-1/A 7 pages This Warrant Shall Be Void if Not Exercised Prior to the Expiration of the Exercise Period Provided for in the Warrant Agreement Described Below Atossa Genetics Inc. Warrant Certificate
12/34/56
EX-4.2
from S-1/A 29 pages Atossa Genetics Inc. Warrant Agency Agreement
12/34/56